Logo image of AVLR

Avalara Inc (AVLR) Stock Fundamental Analysis

NYSE:AVLR - New York Stock Exchange, Inc. - US05338G1067 - Common Stock - Currency: USD

93.48  +0.03 (+0.03%)

After market: 93.49 +0.01 (+0.01%)

Fundamental Rating

3

AVLR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. AVLR has a bad profitability rating. Also its financial health evaluation is rather negative. AVLR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AVLR has reported negative net income.
AVLR had a positive operating cash flow in the past year.
AVLR Yearly Net Income VS EBIT VS OCF VS FCFAVLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA -6.29%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVLR Yearly ROA, ROE, ROICAVLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 200 -200

1.3 Margins

Industry RankSector Rank
OM -19.73%
PM (TTM) -21.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVLR Yearly Profit, Operating, Gross MarginsAVLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 60 -60

More info and screens

3

2. Health

2.1 Basic Checks

AVLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVLR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AVLR is higher compared to a year ago.
AVLR Yearly Shares OutstandingAVLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
AVLR Yearly Total Debt VS Total AssetsAVLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

AVLR has an Altman-Z score of 3.29. This indicates that AVLR is financially healthy and has little risk of bankruptcy at the moment.
AVLR has a Debt/Equity ratio of 0.94. This is a neutral value indicating AVLR is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF N/A
Altman-Z 3.29
ROIC/WACCN/A
WACC11.29%
AVLR Yearly LT Debt VS Equity VS FCFAVLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M 1B

2.3 Liquidity

AVLR has a Current Ratio of 3.18. This indicates that AVLR is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.18 indicates that AVLR has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.18
Quick Ratio 3.18
AVLR Yearly Current Assets VS Current LiabilitesAVLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

7

3. Growth

3.1 Past

The earnings per share for AVLR have decreased strongly by -160.00% in the last year.
Looking at the last year, AVLR shows a very strong growth in Revenue. The Revenue has grown by 32.60%.
Measured over the past years, AVLR shows a very strong growth in Revenue. The Revenue has been growing by 33.09% on average per year.
EPS 1Y (TTM)-160%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)32.6%
Revenue growth 3Y36.96%
Revenue growth 5Y33.09%
Sales Q2Q%23.38%

3.2 Future

Based on estimates for the next years, AVLR will show a very strong growth in Earnings Per Share. The EPS will grow by 103.52% on average per year.
Based on estimates for the next years, AVLR will show a very strong growth in Revenue. The Revenue will grow by 21.63% on average per year.
EPS Next Y106.12%
EPS Next 2Y82.58%
EPS Next 3Y94.62%
EPS Next 5Y103.52%
Revenue Next Year25.99%
Revenue Next 2Y23.42%
Revenue Next 3Y22.75%
Revenue Next 5Y21.63%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AVLR Yearly Revenue VS EstimatesAVLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
AVLR Yearly EPS VS EstimatesAVLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AVLR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 467.37, the valuation of AVLR can be described as expensive.
The average S&P500 Price/Forward Earnings ratio is at 20.89. AVLR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 467.37
AVLR Price Earnings VS Forward Price EarningsAVLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -1K -2K -3K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -69.1
AVLR Per share dataAVLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AVLR does not grow enough to justify the current Price/Earnings ratio.
AVLR's earnings are expected to grow with 94.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.58%
EPS Next 3Y94.62%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVLR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Avalara Inc

NYSE:AVLR (10/18/2022, 8:04:00 PM)

After market: 93.49 +0.01 (+0.01%)

93.48

+0.03 (+0.03%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2022-08-08/bmo
Earnings (Next)11-11 2022-11-11/amc
Inst Owners0.22%
Inst Owner Change0%
Ins Owners13.5%
Ins Owner Change0%
Market Cap8.28B
Analysts68.89
Price Target96.11 (2.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)120%
Min EPS beat(2)73.25%
Max EPS beat(2)166.75%
EPS beat(4)4
Avg EPS beat(4)79.77%
Min EPS beat(4)23.74%
Max EPS beat(4)166.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-2.24%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.75%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)4.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 467.37
P/S 10.49
P/FCF N/A
P/OCF 414.9
P/B 8.07
P/tB 31.46
EV/EBITDA -69.1
EPS(TTM)-0.03
EYN/A
EPS(NY)0.2
Fwd EY0.21%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.23
OCFY0.24%
SpS8.91
BVpS11.59
TBVpS2.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -19.73%
PM (TTM) -21.08%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.18
Quick Ratio 3.18
Altman-Z 3.29
F-Score3
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)59.29%
Cap/Depr(5y)93.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y106.12%
EPS Next 2Y82.58%
EPS Next 3Y94.62%
EPS Next 5Y103.52%
Revenue 1Y (TTM)32.6%
Revenue growth 3Y36.96%
Revenue growth 5Y33.09%
Sales Q2Q%23.38%
Revenue Next Year25.99%
Revenue Next 2Y23.42%
Revenue Next 3Y22.75%
Revenue Next 5Y21.63%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-241.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y197.36%
OCF growth 3YN/A
OCF growth 5YN/A